Wolfe Research Starts Zymeworks (ZYME) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts ZYME Hot Sheet
Price: $28.22 -0.77%
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Rating Summary:
21 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 15
Join SI Premium – FREE
Wolfe Research analyst Kalpit Patel initiates coverage on Zymeworks (NASDAQ: ZYME) with a Outperform rating.
For an analyst ratings summary and ratings history on Zymeworks click here. For more ratings news on Zymeworks click here.
Shares of Zymeworks closed at $26.24 yesterday.
You May Also Be Interested In
- Zymeworks (ZYME) PT Raised to $52 at Jefferies
- Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026
- Craig-Hallum Starts OraSure Technologies (OSUR) at Buy, PT $7
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
